Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001760854-24-000014
Filing Date
2024-12-16
Accepted
2024-12-16 11:32:49
Documents
10
Period of Report
2024-12-16

Document Format Files

Seq Description Document Type Size
1 6-K a6-kformmanagerstransactio.htm 6-K 11196
2 EX-99.1 PDMR NOTIFICATIONS PURSUANT TO MAR exhibit991december16.htm EX-99.1 33943
3 exhibit991december16001.jpg GRAPHIC 85604
4 exhibit991december16002.jpg GRAPHIC 44392
5 exhibit991december16003.jpg GRAPHIC 123783
6 exhibit991december16004.jpg GRAPHIC 55904
7 exhibit991december16005.jpg GRAPHIC 88268
8 exhibit991december16006.jpg GRAPHIC 44390
9 exhibit991december16007.jpg GRAPHIC 123877
10 exhibit991december16008.jpg GRAPHIC 55904
  Complete submission text file 0001760854-24-000014.txt   903436
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39777 | Film No.: 241550747
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)